<ol class="cite-this-references"><li id="reference-A1899">Singh BN, Vaughan Williams EM: The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol. 1970 Aug;39(4):657-67. [<a href="/articles/A1899" target="_blank">Article</a>] </li><li id="reference-A1901">Rosenbaum MB, Chiale PA, Halpern MS, Nau GJ, Przybylski J, Levi RJ, Lazzari JO, Elizari MV: Clinical efficacy of amiodarone as an antiarrhythmic agent. Am J Cardiol. 1976 Dec;38(7):934-44. [<a href="/articles/A1901" target="_blank">Article</a>] </li><li id="reference-A1903">Rosenbaum MB, Chiale PA, Haedo A, Lazzari JO, Elizari MV: Ten years of experience with amiodarone. Am Heart J. 1983 Oct;106(4 Pt 2):957-64. [<a href="/articles/A1903" target="_blank">Article</a>] </li><li id="reference-A36817">Latini R, Tognoni G, Kates RE: Clinical pharmacokinetics of amiodarone. Clin Pharmacokinet. 1984 Mar-Apr;9(2):136-56. doi: 10.2165/00003088-198409020-00002. [<a href="/articles/A36817" target="_blank">Article</a>] </li><li id="reference-A183137">Zipes DP, Prystowsky EN, Heger JJ: Amiodarone: electrophysiologic actions, pharmacokinetics and clinical effects. J Am Coll Cardiol. 1984 Apr;3(4):1059-71. doi: 10.1016/s0735-1097(84)80367-8. [<a href="/articles/A183137" target="_blank">Article</a>] </li><li id="reference-A183140">Riva E, Gerna M, Latini R, Giani P, Volpi A, Maggioni A: Pharmacokinetics of amiodarone in man. J Cardiovasc Pharmacol. 1982 Mar-Apr;4(2):264-9. doi: 10.1097/00005344-198203000-00015. [<a href="/articles/A183140" target="_blank">Article</a>] </li><li id="reference-A189666">Freedman MD, Somberg JC: Pharmacology and pharmacokinetics of amiodarone. J Clin Pharmacol. 1991 Nov;31(11):1061-9. doi: 10.1002/j.1552-4604.1991.tb03673.x. [<a href="/articles/A189666" target="_blank">Article</a>] </li><li id="reference-A189720">Rowland E, Krikler DM: Electrophysiological assessment of amiodarone in treatment of resistant supraventricular arrhythmias. Br Heart J. 1980 Jul;44(1):82-90. doi: 10.1136/hrt.44.1.82. [<a href="/articles/A189720" target="_blank">Article</a>] </li><li id="reference-A189723">Soult JA, Munoz M, Lopez JD, Romero A, Santos J, Tovaruela A: Efficacy and safety of intravenous amiodarone for short-term treatment of paroxysmal supraventricular tachycardia in children. Pediatr Cardiol. 1995 Jan-Feb;16(1):16-9. doi: 10.1007/BF02310328. [<a href="/articles/A189723" target="_blank">Article</a>] </li><li id="reference-A189747">Honjo H, Kodama I, Kamiya K, Toyama J: Block of cardiac sodium channels by amiodarone studied by using Vmax of action potential in single ventricular myocytes. Br J Pharmacol. 1991 Mar;102(3):651-6. doi: 10.1111/j.1476-5381.1991.tb12228.x. [<a href="/articles/A189747" target="_blank">Article</a>] </li><li id="reference-A182168">Narayana SK, Woods DR, Boos CJ: Management of amiodarone-related thyroid problems. Ther Adv Endocrinol Metab. 2011 Jun;2(3):115-26. doi: 10.1177/2042018811398516. [<a href="/articles/A182168" target="_blank">Article</a>] </li><li id="reference-A189829">Ha HR, Bigler L, Binder M, Kozlik P, Stieger B, Hesse M, Altorfer HR, Follath F: Metabolism of amiodarone (part I): identification of a new hydroxylated metabolite of amiodarone. Drug Metab Dispos. 2001 Feb;29(2):152-8. [<a href="/articles/A189829" target="_blank">Article</a>] </li><li id="reference-A189832">Deng P, You T, Chen X, Yuan T, Huang H, Zhong D: Identification of amiodarone metabolites in human bile by ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry. Drug Metab Dispos. 2011 Jun;39(6):1058-69. doi: 10.1124/dmd.110.037671. Epub 2011 Mar 11. [<a href="/articles/A189832" target="_blank">Article</a>] </li><li id="reference-A20227">Szalowska E, van der Burg B, Man HY, Hendriksen PJ, Peijnenburg AA: Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices. PLoS One. 2014 Jan 29;9(1):e86795. doi: 10.1371/journal.pone.0086795. eCollection 2014. [<a href="/articles/A20227" target="_blank">Article</a>] </li><li id="reference-A20650">Song M, Kim YJ, Ryu JC: Phospholipidosis induced by PPARgamma signaling in human bronchial epithelial (BEAS-2B) cells exposed to amiodarone. Toxicol Sci. 2011 Mar;120(1):98-108. doi: 10.1093/toxsci/kfq361. Epub 2010 Dec 1. [<a href="/articles/A20650" target="_blank">Article</a>] </li><li id="reference-L2908">Electronic Medicines Compendium Amiodarone 100mg Tablets [<a href="https://www.medicines.org.uk/emc/product/6019/smpc" target="_blank">Link</a>] </li><li id="reference-L8087">Nexterone FDA label [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/022325lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L3561">FDA Approved Drug Products: CORDARONE (amiodarone HCl) tablets [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/018972s054lbl.pdf" target="_blank">Link</a>] </li><li id="reference-L11265">NIH StatPearls: Amiodarone [<a href="https://www.ncbi.nlm.nih.gov/books/NBK482154/" target="_blank">Link</a>] </li><li id="reference-L11286">AAFP: Medication Guide for Amiodarone [<a href="https://www.aafp.org/afp/2005/0401/p1434.html" target="_blank">Link</a>] </li><li id="reference-L6994">FDA Approved Drug Products: NEXTERONE (amiodarone HCl) injection [<a href="https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/022325s013lbl.pdf" target="_blank">Link</a>] </li></ol>